The Inventory Control, Storage Facilities and Distribution at Pharmaceutical Industry in Supporting Drugs Availability of JKN Era

https://doi.org/10.22146/jmpf.43162

Satibi Satibi(1*), Achmad Fudholi(2), Eirene Copalcanty Tuko(3), Gabriela Larasati Swastiandari(4)

(1) Faculty of Pharmacy Universitas Gadjah Mada
(2) Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta
(3) Graduate School of Pharmaceutical Management, Faculty of Pharmacy, Universitas Gadjah Mada
(4) Graduate School of Pharmaceutical Management, Faculty of Pharmacy, Universitas Gadjah Mada
(*) Corresponding Author

Abstract


The drugs availability is still a problem in the health system in Indonesia. The number of JKN participants increasing the need for generic drugs. Pharmaceutical industry has a role to produce affordable and good quality medicines by implementing good supply chain. The purpose of this study was to identify the role of inventory control, storage and distribution facilities in the pharmaceutical industry in supporting drugs availability in the JKN era. This is a descriptive research with qualitative method and uses purposive sampling. Data was collected in depth interview with employees from the PPIC and SCM in Pharma A, Pharma B, Pharma C and Pharma D that collaborated with BPJS Kesehatan and become drug providers in e-catalogue tender. Data analysis consisted of making interview transcripts, interpreting data, and triangulation. The results of the analysis showed that inventory control has an influence in the pharmaceutical industry in supporting the drugs availability due to a mismatch between demand and need, thereby increasing the occurrence of stock over or stock out. Facilities of storage has an influence in the pharmaceutical industry in supporting the drugs availability due to overload storage facilities so that the storage method was not optimal and has to pay other costs to rent warehouses. Distribution has an influence in the pharmaceutical industry in supporting the drugs availability because the costs for distribution must reach a minimum order to be distributed and the choice of transportation modes for distribution may be increased the lead time that caused the drug vacancies.

Keywords


ketersediaan obat, industri, e-catalogue, JKN.

Full Text:

PDF


References

1. Yunarto N. Revitalisasi Obat Generik: Hasil Uji Disolusi Obat Generik Tidak Kalah Dengan Obat Bermerk. Media Penelit dan Pengemb Kesehat. 2010;XX(4):198-202.

2. Patunrui KIA, Yati S. Analisis Penilaian Financial Distress Menggunakan Model Altman ( Z- Score ) Pada Perusahaan Farmasi Yang Terdaftar di Bursa Efek Indonesia Periode 2013-2015. J Akuntansi, Ekon dan Manaj Bisnis. 2017;5(1):55-71.

3. Dristiana F, Sukmono T. Pengendalian Persediaan Bahan Baku Obat Dengan Menggunakan Metode Eoq Probabilistik Berdasarkan Peramalan Exponential Smoothing Pada. Spektrum Ind. 2015;13(2):115-228.

4. Anwar SN. Manajemen Rantai Pasokan (Supply Chain Management): Konsep dan Hakikat. J Din Inform. 2011;3(4):92-98.

5. Rianda A, Oktafani SE, Akmal I, Khairani Z, Gilang D.P. M. Sistem Rantai Pasok Produk Obat-Obatan. J Optimasi Sist Ind. 2011;10(2):160-165.

6. Dwiaji A, Sarnianto P, Thabrany H, Syarifudin M. Evaluasi Pengadaan Obat Publik Pada JKN Berdasarkan Data e-Catalogue Tahun 2014-2015. J Ekon Kesehat Indones. 2016;1(1):15. http://journal.fkm.ui.ac.id/jurnal-eki/article/ view/1933/641.

7. Nurtantijo AN, Kuswinarti, Sunjaya DK. Analisis Ketersediaan Obat pada era Jaminan Kesehatan Nasional di Apotek Wilayah Bojonegara Kotamadya Bandung Tahun 2015. J Sist Kesehat. 2016;1(4):165-170.

8. Mendrofa DE, Suryawati C. Analisis Pengelolaan Obat Pasien BPJS Di Instalasi Farmasi Rumah Sakit Panti Wilasa Citarum Semarang. Manaj Kesehat Indones. 2016;4(3):214-221.

9. Ali FA, Kandou GD, Umboh JML. Analisis Pelaksanaan Rujukan Rawat Jalan Tingkat Pertama Peserta Program Jaminan Kesehatan Nasional (JKN) Di Puskesmas Siko Dan Puskesmas Kalumata Kota Ternate Tahun 2014. J Ilmu Kesehat Masy Unsrat. 2015;5(2):221-237. http://ejournal.unsrat.ac.id/ index.php/jikmu/article/view/7439.

10. Carolien I, Fudholi A, Endarti D. Evaluasi Ketersediaan Obat Sebelum dan Sesudah Implementasi JKN pada Puskesmas di Kabupaten Keerom Provinsi Papua. J Manaj dan Pelayanan Farm. 2017;7(1):30-39.

11. Gauthfa A, Kuswinarti, Sunjaya D. Dampak Implementasi Jaminan Kesehatan Nasional terhadap ketersediaan Obat di Apotek Rujukan Wilayah Cibeunying Kotamadya Bandung Tahun 2015. J Sist Kesehat. 2016;1(4):159-164. http://journal.unpad.ac.id/jsk_ikm/article/view/10374/4736.

12. Raharni, Supardi S, Sari ID. Kemandirian dan Ketersediaan Obat Era Jaminan Kesehatan Nasional (JKN): Kebijakan, Harga, dan Produksi Obat. Media Litbangkes. 2018;28(4):219-228.

13. Septiadi MA. Implementasi Peraturan Bupati Kutai Kartanegara Nomor 16 Tahun 2008 Tentang Penyelenggaraan System Jaminan Kesehatan Daerah di Kabupaten Kutai Kartanegara (Studi Kasus Di Puskesmas Muara Jawa). eJournal Ilmu Pemerintah. 2013;1(1):16-30.

14. Khariza HA. Program Jaminan Kesehatan Nasional : Studi Deskriptif Tentang Faktor-Faktor Yang Dapat Mempengaruhi Keberhasilan Implementasi Program Jaminan Kesehatan Nasional. J Kebijak dan Manaj Publik. 2015; 3(1):1-7.

15. Agussalim, Hermiyanti, Abd.Rahman. Analisis Implementasi Kebijakan Jaminan Kesehatan Nasional (JKN) di Rumah Sakit Umum Daerah (RSUD) Undata Palu. J Kesehat Tadulako. 2017;3(1):62-70.

16. Honesty AS. Upaya Indonesia dalam Menangani Pemalsuan Obat melalui Member State Mechanism tahun 2012-2016. J Int Relat. 2017;3(1):123-130.

17. Bambang P. Bab 6. Manajemen Produksi & Operasi Industri Farmasi. In: Manajemen Farmasi Industri. Yogyakarta: Global Pustaka Utama; 2007.

18. Ketkar M, Vaidya OS. Developing Ordering Policy based on Multiple Inventory Classification Schemes. J Procedia - Soc Behav Sci. 2014;133(Mcdm):180-188.

19. Fang Y. Pharmaceutical policy in China. J Pharm Policy Ctries with Dev Healthc Syst. 2017;4(4):169-191. doi:10.1007/978-3-319-51673-8_9

20. Dzikrillah N, Purba HH, Suwazan D, Wahjoedi N. Produk Strategi. J Tek Ind. 2016;(29):161-166.

21. Talib A, Garai A. Just in Time Approach in Inventory Management. J Technol Manag Bus Entrep. 2013:1-9.

22. Kemenkes. Peraturan Menteri Kesehatan Tahun 2010 Tentang Kewajiban Menggunakan Obat Generik Di Fasilitas Kesehatan Pemerintah. Indonesia; 2010.

23. Santhi G, K K. Recent Review Article on Pharmaceutical Inventory Models. Int J PharmaTech Res. 2016;9(5).

24. Shafaat K, Hussain A, Kumar B, ul Hasan R, Prabhat P K V. An overview: storage of pharmaceutical products. J Pharm Pharm Sci. 2013;2(5):2499-2515.

25. Mustamu R. Manajemen Rantai Pasokan Industri. J Manaj dan Kewirausahaan. 2007;9(2):99-106.

26. Abdallah AA. Global Pharmaceutical Supply Chain : A Quality Perspective. J Bus Manag. 2013;8(17):62-70.

27. Lachman L, Herbert AL, Joseph LK. Teori Dan Praktek Industri Farmasi Edisi 3. 3rd ed. Jakarta: Penerbit Universitas Indonesia; 2008.

28. Susandi D, Widianto T. Distribution Requirement Planning Sediaan Obat dan Perlengkapan Kesehatan Konsumen/Agen PT. SBF Cirebon. J Ind Serv. 2015;1(1):1-6.

29. Aigbogun O, Ghazali Z, Razali R. A Framework to Enhance Supply Chain Resilience The Case of Malaysian Pharmaceutical Industry. J Glob Bus Manag Res An Int J. 2014;6(3):219-228.

30. Moharana HS, Murty JS, Senapati SK, Khuntia K. Coordination, Collaboration and Integration for Supply Chain Management. J Intersci Manag Rev. 2012;(22):2231-1513.




DOI: https://doi.org/10.22146/jmpf.43162

Article Metrics

Abstract views : 8112 | views : 64249

Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

©Jurnal Manajemen dan Pelayanan Farmasi
Faculty of Pharmacy
Universitas Gadjah Mada
Creative Commons License
View My Stats